US Patent 11858919 HDAC1,2 inhibitors
Patent 11858919 was granted and assigned to Regenacy Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 25, 2019
0
Date of Patent
January 2, 2024
0
Patent Applicant
Patent Application Number
17278485
0
Patent Citations
Patent Inventor Names
Charles Blum
0
Ralph Mazitschek
0
John H. Van Duzer
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11858919 HDAC1,2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
